MedPath

COVID-19 Patients Admitted to the ICU

Conditions
Covid19
Interventions
Other: no intervention will be administered, this is a retrospective observational study.
Registration Number
NCT04816786
Lead Sponsor
Ministry of Health, Kuwait
Brief Summary

A retrospective analysis of the adult COVID-19 patients admitted to the ICU. A chart review will be conducted and multiple baseline characteristics, demographics, and treatments given will be recorded.

Variables collected will include Age, Gender, BMI, Smoking status, Past medical history, Vital signs on admission, symptoms on admission, duration of symptoms, laboratory results on admission, treatment given. Treatment options will include (Steroids, plasma exchange, IVIG, antibiotics, mode of respiratory support).

Primary outcomes will include; Death, duration of ICU stay, duration of mechanical ventilation, in-hospital complications.

A regression model will be used to predict poor prognostic factors. Inclusion criteria: patients with confirmed PCR results for COVID-19 AND require ICU admission. Exclusion criteria: those with negative results, pediatric patients and those not requiring ICU admission.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Adults
  • Positive PCR test for COVID-19
  • Require admission to ICU
Exclusion Criteria
  • Pediatric patients\
  • Any patient not requiring admission to ICU

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Group 1: Admitted to ICU and died during the hospital stay.no intervention will be administered, this is a retrospective observational study.-
Group 2: Admitted to ICU was were discharged.no intervention will be administered, this is a retrospective observational study.-
Primary Outcome Measures
NameTimeMethod
Death30 day mortality

Death Vs No Death

Duration of mechanical ventilation30 days

The duration the patient required support from a mechanical ventilator

Duration of ICU stay30 days

Duration of ICU stay

Secondary Outcome Measures
NameTimeMethod
In-Hospital complications30 days

Wether patients developed in hospital complications.

Trial Locations

Locations (1)

Mubarak al Kabeer hospital

🇰🇼

Kuwait, Outside U.S./Canada, Kuwait

© Copyright 2025. All Rights Reserved by MedPath